NCT05667246
Clinical Effect of Caffeine Consumption in Patients Taking Oral Terbinafine
Enrolling by Invitation
NAAges 18+InterventionalSupportive careWeill Medical College of Cornell UniversityInvestigator-initiated
~52 participants
Updated 2025-10-01 on ClinicalTrials.gov
What's tested:Caffeinated CoffeeDecaffeinated Coffee
At a glance
Recruiting sites
0 of 1 listed site is recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Change in Blood Pressure
Measured over Baseline, 30 min after consuming caffeine, 60 minutes after consuming caffeine
+1 more outcome measured
Conditions
Where it's being run
1 sites across 1 statesNew York1
Study leadership
- Shari Lipner, MD, PhD · PRINCIPAL_INVESTIGATOR · Weill Medical College of Cornell University
Who to contact
This trial hasn't published a contact. View it on ClinicalTrials.gov
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Eligibility criteria
Inclusion
Patient of any gender at least 18 years of age
Diagnosed with onychomycosis
Planning to start oral terbinafine
Exclusion
Pregnant or breastfeeding
Any history of anxiety or hypertension
Any patient with an inability to give consent
What this trial measures
- Change in Blood PressureBaseline, 30 min after consuming caffeine, 60 minutes after consuming caffeine
An inflatable cuff will be placed around the subject's arm. The cuff has a gauge on it that will measure the blood pressure.
- Change in Heart RateBaseline, 30 min after consuming caffeine, 60 minutes after consuming caffeine
A heart rate monitor will be used to measure the pulse of the subject.